Elisabeth Sandoval

Insider Reports History

Entity
Individual
Location
C/O Kythera Biopharmaceuticals, Inc., 30930 Russell Ranch Road, 3 Rd Floor, Westlake Village, CA
Signature
/s/ Mutya Harsch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elisabeth Sandoval:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PROCEPT BioRobotics Corp Director Common Stock 11K $706K $64.04 Jun 4, 2024 Direct
PROCEPT BioRobotics Corp Director Stock Option (Right to Buy) 2.53K $11.5K $4.56 Jun 4, 2024 Direct
VYNE Therapeutics Inc. Director Stock Option (right to buy) 20K Dec 12, 2024 Direct
Intersect ENT, Inc. Director Stock Options (Right to buy) 0 $28.25 May 13, 2022 Direct
Satsuma Pharmaceuticals, Inc. Director Stock Option (right to buy) 0 Jun 8, 2023 Direct

Insider Reports Filed by Elisabeth Sandoval

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VYNE VYNE Therapeutics Inc. Dec 12, 2024 1 $0 4 Dec 13, 2024 Director
PRCT PROCEPT BioRobotics Corp Jun 4, 2024 2 $0 4 Jun 6, 2024 Director
VYNE VYNE Therapeutics Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director
VYNE VYNE Therapeutics Inc. Dec 13, 2023 1 $0 4 Dec 15, 2023 Director
PRCT PROCEPT BioRobotics Corp Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
STSA Satsuma Pharmaceuticals, Inc. Jun 8, 2023 4 $0 4 Jun 8, 2023 Director
VYNE VYNE Therapeutics Inc. Aug 10, 2022 1 $0 4 Aug 12, 2022 Director
PRCT PROCEPT BioRobotics Corp Jun 7, 2022 2 $75K 4 Jun 9, 2022 Director
STSA Satsuma Pharmaceuticals, Inc. Jun 3, 2022 1 $0 4 Jun 7, 2022 Director
XENT Intersect ENT, Inc. May 13, 2022 1 -$449K 4 May 16, 2022 Director
PRCT PROCEPT BioRobotics Corp Oct 21, 2021 1 $200K 4 Oct 25, 2021 Director
VYNE VYNE Therapeutics Inc. Jul 19, 2021 1 $0 4 Jul 20, 2021 Director